XML 63 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of Categorization of Assets and Liabilities Measured at Fair Value
The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the years ended December 31, 2022 and 2021, there were no transfers between Levels 2 and 3.


 
  
December 31, 2022
 
 
  
Total
 
  
Level 1
 
  
Level 2
 
  
Level 3
 
Assets:
                               
Recurring fair value measurements:
                               
Cash equivalents
  $ 930     $ 930     $ —       $ —    
Financial instruments owned, at fair value
                               
ETFs
    23,772       23,772       —         —    
U.S. treasuries
    2,980       2,980       —         —    
Pass-through GSEs
    96,837       23,290       73,547       —    
Corporate bonds
    885       —         885       —    
Other assets—seed capital
    1,765       —         1,765       —    
Investments in Convertible Notes
                               
Securrency, Inc.—convertible note (Note 8)
    14,500       —         —         14,500  
Fnality International Limited—convertible note (Note 8)
    6,921       —         —         6,921  
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $
 
 
148,590
    $
 
 
 
 
50,972
    $
 
 
 
 
76,197
    $ 21,421  
   
 
 
   
 
 
   
 
 
   
 
 
 
Non-recurring
fair value measurements:
                               
Other investments
(1)
  $ 312     $ —       $ —       $ 312  
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
                               
Recurring fair value measurements:
                               
Deferred consideration (Note 10)
  $ 200,290     $ —       $ —       $
 
 
200,290
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
 
Fair value determined on May 10, 2022.
 
 
  
December 31, 2021
 
 
  
Total
 
  
Level 1
 
  
Level 2
 
  
Level 3
 
Assets:
  
  
  
  
Recurring fair value measurements:
  
  
  
  
Cash equivalents
  $ 11,488     $ 11,488     $ —       $ —    
Financial instruments owned, at fair value
                               
ETFs
    18,812       18,812       —         —    
Pass-through GSEs
    106,245       24,720       81,525       —    
Corporate bonds
    2,109       —         2,109       —    
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $
 
 
138,654
    $
 
 
 
 
55,020
    $
 
 
 
 
83,634
    $ —    
   
 
 
   
 
 
   
 
 
   
 
 
 
Non-recurring
fair value measurements:
                               
Securrency, Inc.—Series A convertible preferred stock
(1)
  $ 8,488     $ —       $ —       $ 8,488  
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
                               
Recurring fair value measurements:
                               
Deferred consideration (Note 10)
  $ 228,062     $ —       $ —       $
 
 
228,062
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
 
Fair value of $8,488 and $8,349 determined on June 9, 2021 and March 8, 2021, respectively (Note
8
).
Summary of Reconciliation of Recurring Fair Value Measurements The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:
 
 
 
  
Years Ended

December 31,
 
  
2022
 
2021
Investments in Convertible Notes (Note 8)
  
 
Beginning balance
 
 
$
—      
 
$
—    
Purchases
    21,863       —    
Net unrealized losses
(1)
    (442 )
 
 
    —    
 
 
 
 
 
 
 
 
 
Ending balance
  $ 21,421     $ —    
 
  
 
 
 
 
 
 
 
Deferred Consideration (Note 10)
               
Beginning balance
  $ 228,062     $ 230,137  
Net realized losses
(2)
    17,108       17,096  
Net unrealized gains
(3)
    (27,765     (2,018 )
 
 
Settlements
    (17,115     (17,153
 
 
 
 
 
 
 
 
 
Ending balance
  $
 
 
 
 
 
 
200,290
    $
 
 
 
 
 
 
228,062
 
 
 
 
 
 
 
 
 
 
 
(
1)
 
Recorded in other losses and gains, net in the Consolidated Statements of Operations.
(2)
 
Recorded as contractual gold payments expense in the Consolidated Statements of Operations.
(3)
 
Recorded as gain on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.